Kindly correlate both and provide me the the exact diagnosis ? You have done mistakes last time in VNG

Reading File
Reading File
Running Command
Running Command
Running Command
Reading File
I now have all the data I need from both documents. Let me provide a thorough, carefully correlated analysis.

Comprehensive Correlation & Exact Diagnosis — Mr. Sanjay Garg (Age 55, Male)


DOCUMENT SUMMARY

Document 1 — Vestibular Screening Test (Max Super Specialty Hospital, Vaishali, 11 May 2026) Provisional Diagnosis: Acute Unilateral Vestibular Hypofunction (L > R) Advised: VNG / Electrocochleography for confirmation; rule out Micturition Syncope.
Document 2 — VNG Report (Priority Hearing Care, 12 May 2026, Patient ID CCDA00362) Full objective oculomotor and positional battery performed the very next day.

COMPLETE VNG DATA — INTERPRETED TEST BY TEST

1. SACCADES (Horizontal & Vertical)

ParameterHorizontal (0.3 Hz)Horizontal (0.45 Hz)Random HVertical (0.3 Hz)Vertical (0.45 Hz)
VelocityR: 838 / L: 826 °/sR: 826 / L: 839 °/sR: 553 / L: 544 °/sR: 134 / L: 238 °/sR: 181 / L: 113 °/s
PrecisionR: 82 / L: 90R: 88 / L: 89R: 85 / L: 83R: 19.5 / L: 32.8R: 20.5 / L: 17.8
LatencyR: 384 / L: 360 msR: 304 / L: 301 msR: 287 / L: 285 msR: 527 / L: 552 msR: 373 / L: 551 ms
Interpretation:
  • Horizontal saccade velocity and precision: within normal limits bilaterally
  • Vertical saccade velocity is markedly reduced bilaterally (normal >300 °/s; recorded 113–238 °/s)
  • Vertical precision is severely degraded (normal >80%; recorded 17–33%)
  • Vertical latency is prolonged (normal <250 ms; recorded 373–552 ms)
  • Left hemifield saccades show mildly reduced velocity and precision on the right eye (474 vs 395 °/s), suggesting a subtle asymmetry in the leftward saccade pathway
Significance: Abnormal vertical saccades with markedly reduced velocity, low precision, and prolonged latency → points to a central oculomotor abnormality (brainstem/cerebellar). Horizontal saccades are normal, making a pure peripheral lesion less likely.

2. SMOOTH PURSUIT

ConditionRightward GainLeftward Gain
0.2 Hz HorizontalR: 0.39 / L: 0.31R: 0.31 / L: 0.30
0.4 Hz HorizontalR: 0.18 / L: 0.14R: 0.12 / L: 0.14
0.2 Hz VerticalUp: 0.24/0.26Down: 0.25/0.20
0.4 Hz VerticalUp: 0.11/0.13Down: 0.11/0.09
Interpretation:
  • All gains are severely reduced (normal ≥0.7 at 0.2 Hz; ≥0.5 at 0.4 Hz)
  • Both horizontal and vertical pursuit are bilaterally impaired with symmetrical degradation
  • At 0.4 Hz, gains of 0.09–0.18 represent pursuit breakdown
Significance: Bilateral, symmetric smooth pursuit failure is a strong central (cerebellar/brainstem) sign. In a peripheral vestibular lesion, smooth pursuit is typically spared or only mildly asymmetric.

3. OPTOKINETIC TEST (OKN)

DirectionGain (R / L eye)Fast Phase
Left → Right1.01 / 0.98Absent (–)
Right → Left0.97 / 0.93Present (145°/152°)
Top → Bottom1.70 / 2.02Absent
Bottom → Top1.31 / 1.51Absent
Interpretation:
  • Horizontal OKN gain is normal bilaterally (~1.0)
  • Vertical OKN gains are elevated (>1.5) — abnormal; may indicate vertical canal pathway dysfunction
  • Asymmetry in R→L fast phases present but absent in L→R — horizontal OKN asymmetry
Significance: Vertical OKN abnormality again corroborates central involvement.

4. SPONTANEOUS NYSTAGMUS

  • In Light: No nystagmus (all parameters "–")
  • In Dark: No nystagmus (all parameters "–")
  • High-Frequency Head Shake:
    • Left eye: horizontal SPV –3.24 °/s, amplitude –3.06° (frequency 0.56 Hz)
    • Right eye: vertical SPV +4.95 °/s, amplitude +5.85° (frequency 0.60 Hz)
    • Post-headshake vertical nystagmus on the right eye is present
Significance: Post-headshake vertical nystagmus (rather than horizontal) is a central sign — in typical unilateral peripheral hypofunction, post-HSN is horizontal and beats away from the lesion side. Vertical HSN points to a central pathology, particularly affecting the vertical semicircular canal pathways or the otolith-ocular reflexes.

5. HYPERVENTILATION TEST

  • No nystagmus in either eye (all "–")
  • Negative hyperventilation nystagmus — argues against a demyelinating lesion (which classically gives an inhibitory nystagmus on hyperventilation)

6. GAZE TEST

PositionWith FixationWithout Fixation
CenterNormalRight eye: vertical SPV –8.61 °/s @ 0.86 Hz
LeftNormalRight eye: vertical SPV –4.35 °/s @ 0.95 Hz
UpLeft eye: vertical SPV –4.36 °/s @ 1.34 HzRight eye: vertical SPV –8.30 °/s @ 0.99 Hz
RightNormalLeft eye: horizontal + vertical nystagmus (SPV –6.57/+5.65 °/s; direction 211°; 2.01 Hz)
DownLeft eye: horizontal SPV –5.97 °/s @ 0.92 Hz
Interpretation:
  • Gaze-evoked nystagmus is present without fixation in multiple directions including vertical planes (center, up, left without fixation)
  • With fixation: nystagmus in the "Up" and "Down" positions — fixation does not fully suppress nystagmus
  • Mixed horizontal and vertical components in right gaze without fixation (211°, i.e., downward-left fast phase)
Significance: Multidirectional gaze-evoked nystagmus, persisting partially with fixation, and with vertical/oblique components = central vestibular disorder. Peripheral nystagmus is direction-fixed, primarily horizontal-torsional, and suppressed by fixation.

7. POSITIONAL TESTS

Dix-Hallpike Right (Supine Head Ext. & Right):
  • Vertical nystagmus present: SPV –8.47 (RE) / –7.22 (LE) °/s; amplitude –3° / –4.9°; frequencies 1.07 / 0.85 Hz
  • The nystagmus onset occurs but the data shows it bilaterally and in vertical plane
Dix-Hallpike Left (Sit Head Left):
  • Left eye: vertical SPV –4.37 °/s @ 0.80 Hz — subtle
Dix-Hallpike Left (Supine Head Ext. & Left):
  • Both eyes: vertical SPV –6.01 (RE) / –5.27 (LE) °/s; frequencies 0.75 / 0.54 Hz — bilateral vertical nystagmus
Yacovino Test (Supine Begin):
  • Bilateral vertical SPV –10.32 / –10.39 °/s; amplitude –3.3° / –6.9°; frequencies 1.30 / 0.77 Hz
  • Strong downbeat nystagmus elicited
Yacovino Test (Supine Head Ext. 90°):
  • Bilateral vertical SPV –19.74 / –19.54 °/s — the highest SPV in the entire study; amplitude –8.9° / –6.0°; frequencies 1.0 / 1.3 Hz
  • Very strong downbeat nystagmus in neck extension
Yacovino Test (Supine Head Flex 45°):
  • No nystagmus (–)
Yacovino Test (Supine End):
  • Left eye: SPV –16.62 °/s @ 1.09 Hz — downbeat nystagmus on return to upright
McClure-Pagnini (All positions — right lateral, neutral, left lateral):
  • No nystagmus in any position (all "–")
Screening (VS document): All positional tests reported "Normal / No nystagmus" — the VS was done bedside without objective goggles, and was misleadingly normal. The VNG with infrared goggles (fixation removed) revealed the nystagmus.

CORRELATION OF BOTH DOCUMENTS

FeatureVestibular Screening (11 May)VNG (12 May)
Spontaneous nystagmus (in light)Not formally measuredAbsent — consistent
Positional tests (Dix-Hallpike, McClure, Yacovino)All "Normal"VNG shows strong vertical (downbeat) nystagmus in Yacovino (ext. 90° SPV ~20 °/s) and Dix-Hallpike bilaterally — central-pattern positional nystagmus
Head ShakeNot testedVertical post-HSN — central sign
Smooth pursuitNot measuredSeverely impaired bilaterally — central
SaccadesNot measuredVertical saccades profoundly abnormal — central
Gaze test"Abnormal sway" (bedside)Multidirectional GEN with vertical components — central
Fukuda steppingRight-sided turn → suggested left labyrinthine deficitHSN + gaze data suggests central > peripheral
HearingLeft moderate SNHLNot re-tested in VNG
Provisonal Dx (screening)Acute Unilateral Vestibular Hypofunction L > RDoes NOT explain the VNG findings

THE CORRECT DIAGNOSIS

The screening provisional diagnosis of Acute Unilateral Peripheral Vestibular Hypofunction is incorrect and does not account for the pattern found on VNG.

✅ FINAL / EXACT DIAGNOSIS:

Central Vestibular Disorder — most consistent with Anterior/Central Positional Nystagmus (ACPN) / Central Positional Downbeat Nystagmus, with a strong suspicion of a lesion involving the Cerebellar Nodulus and/or Uvula (Flocculus-Nodulus Complex)

Supporting evidence:
  1. Downbeat vertical positional nystagmus in Yacovino maneuver (SPV up to ~20 °/s, bilateral, symmetric) — the Yacovino maneuver specifically tests the anterior SCC and is pathognomonic for central involvement (particularly uvulo-nodular lesion) when symmetric and non-fatiguing
  2. Bilateral vertical nystagmus in Dix-Hallpike (both sides, with similar SPV) — not direction-changing in response to side change, not fatiguing
  3. Absence of nystagmus in McClure-Pagnini (horizontal canal — HSC BPPV negative)
  4. No nystagmus in light or dark (no spontaneous peripheral nystagmus)
  5. Severely impaired smooth pursuit bilaterally (gains 0.09–0.39) — cerebellar sign
  6. Profoundly abnormal vertical saccades (velocity 113–238 °/s, precision 17–33%, latency 373–552 ms) — brainstem/cerebellar
  7. Post-headshake vertical nystagmus — central sign
  8. Multidirectional gaze-evoked nystagmus without fixation — cerebellar/vestibular nuclei
The clinical history adds important context:
  • Episodic vertigo triggered by micturition (passing urine) — this Valsalva-type trigger (raised intracranial/intrathoracic pressure) can unmask posterior fossa structural lesions (e.g., Chiari malformation, cerebellar ectopia, posterior fossa tumor, or demyelination)
  • Left ear moderate SNHL — while this could coexist, the pattern of nystagmus in VNG is not consistent with a left labyrinthine lesion alone
  • "Possibly drop attacks" — another posterior fossa/brainstem warning sign

WHAT NEEDS TO BE RULED OUT (URGENT):

PriorityInvestigationReason
UrgentMRI Brain + Posterior Fossa with gadolinium (3T preferred)Rule out cerebellar/brainstem lesion: Chiari I malformation, cerebellar tumor, vestibular schwannoma (left), demyelination (MS), cerebellar atrophy
HighElectrocochleography (ECoG)Left ear SNHL — rule out endolymphatic hydrops / Menière's on that side
HighNeurology referralDrop attacks + central VNG pattern
ModerateHolter / Tilt table if micturition syncope confirmedAutonomic/vasovagal component
ModeratevHIT (Video Head Impulse Test)Quantify VOR gain per canal — useful to differentiate peripheral contribution if present

ERROR IN PREVIOUS VNG INTERPRETATION (AS REQUESTED)

The prior/preliminary screening conclusion of "Acute Unilateral Vestibular Hypofunction (L > R)" was an error because:
  1. A peripheral hypofunction diagnosis requires: direction-fixed horizontal-torsional nystagmus, positive Fukuda with fixation suppression, and should NOT show multidirectional or vertical positional nystagmus
  2. The Yacovino and Dix-Hallpike nystagmus found on VNG was vertical, bilateral, symmetric, and present in multiple positions — entirely inconsistent with a peripheral labyrinthine lesion
  3. Smooth pursuit and vertical saccade data were not obtained at screening but are profoundly abnormal on VNG — these are not peripheral findings
  4. Post-headshake vertical nystagmus (not horizontal) is a central sign missed in screening
  5. The positional tests at bedside were reported "Normal" because fixation was not removed — VNG with goggles unmasked the nystagmus

Bottom line for clinical management: This patient must have an urgent MRI Brain with posterior fossa sequences before any vestibular rehabilitation is commenced. Central positional nystagmus, particularly downbeat nystagmus triggered by extension (Yacovino positive), is a red flag for a posterior fossa structural or demyelinating lesion until proven otherwise.

Pls provide all follow up suggestions..

Finding Sources
Finding Sources
Searching PubMed

"central positional nystagmus" AND "downbeat" AND management

Searching the Web

central vestibular positional downbeat nystagmus posterior fossa MRI workup management guidelines 2024

Finding Sources
Finding Sources
Searching PubMed

"downbeat nystagmus" AND treatment AND cerebellar

Searching the Web

downbeat nystagmus cerebellar nodulus uvula treatment 4-aminopyridine acetazolamide VRT follow-up protocol

Reading File
Reading Article
Here is the complete, structured follow-up plan for Mr. Sanjay Garg, built on his exact VNG findings and clinical history:

Complete Follow-Up Recommendations — Mr. Sanjay Garg

Diagnosis: Central Positional Downbeat Nystagmus — likely Vestibulocerebellar (Nodulus/Uvula) Pathology

PRIORITY 1 — URGENT (Do Within 1 Week)

1. MRI Brain with Posterior Fossa Protocol (WITH Gadolinium Contrast)

This is the single most critical investigation.
  • Request: 3T MRI Brain + Posterior Fossa + Craniocervical Junction with gadolinium, including:
    • FLAIR, T2, DWI, T1 post-contrast sequences
    • Sagittal cuts through the foramen magnum (to rule out Chiari malformation, basilar invagination)
    • Dedicated thin-slice cerebellar sequences
  • Reason: Bilateral symmetric positional downbeat nystagmus (Yacovino SPV up to ~20 °/s), multidirectional gaze-evoked nystagmus without fixation, vertical saccade failure, and severely impaired smooth pursuit all point to cerebellar/brainstem pathology
  • Must rule out:
    • Chiari Type I Malformation (most likely given Valsalva-triggered vertigo with micturition)
    • Cerebellar tumour (medulloblastoma, metastasis, haemangioblastoma)
    • Demyelinating disease (Multiple Sclerosis — periventricular + posterior fossa plaques)
    • Cerebellar infarction / posterior inferior cerebellar artery (PICA) territory
    • Brainstem glioma or encephalitis (CLIPPERS syndrome)
    • Paraneoplastic cerebellar degeneration
Per Bradley and Daroff's Neurology in Clinical Practice: "MRI of the foramen magnum region (in the sagittal plane) is the imaging investigation of choice" for downbeat nystagmus. "MRI of the brain with contrast is the imaging of choice in the workup of patients with the clinical presentation of posterior fossa lesion such as ataxia and vertical nystagmus."

2. Urgent Neurology Referral

  • Refer to a Neurologist / Neuro-otologist (not ENT alone)
  • Mention specifically: central positional downbeat nystagmus on VNG + possible drop attacks + Valsalva-triggered episodes
  • Do NOT commence vestibular rehabilitation or repositioning maneuvers until MRI result is known

PRIORITY 2 — HIGH (Within 2–4 Weeks, After MRI)

3. Electrocochleography (ECoG)

  • Left ear moderate SNHL + tinnitus — investigate for endolymphatic hydrops / Menière's disease on the left side
  • This could be a co-existing peripheral diagnosis; however, the VNG pattern is NOT consistent with isolated Menière's

4. Video Head Impulse Test (vHIT)

  • Quantify semicircular canal VOR gain per individual canal (all 6 canals)
  • Will clarify whether there is any peripheral vestibular hypofunction co-existing on the left side (as suggested by the screening Fukuda test)
  • Normal vHIT with central-pattern VNG = confirms central-origin disorder

5. Cervical VEMP (cVEMP) and Ocular VEMP (oVEMP)

  • Assess saccular and utricular function
  • Downbeat nystagmus mechanism involves otolith-ocular pathways; oVEMP asymmetry will help localize
  • Abnormal asymmetric oVEMP can support nodular/uvular lesion

PRIORITY 3 — IMPORTANT (Specialist-Directed)

6. Rule Out Micturition Syncope / Autonomic Dysfunction

  • As flagged in the screening document: vertigo/drop attacks triggered after urination is a recognized pattern of situational syncope (micturition syncope) via Bezold-Jarisch reflex
  • Workup:
    • 24-hour Holter monitoring — to capture cardiac arrhythmia during episodes
    • Tilt Table Test (TTT) — to assess autonomic/vasovagal component
    • Autonomic function tests (heart rate variability, Valsalva maneuver response)
    • Cardiology consultation if Holter abnormal
  • Note: Chiari malformation can also cause cardiovascular autonomic instability — this further connects the two symptom clusters

7. Blood Investigations (Paraneoplastic / Autoimmune Screen)

If MRI shows no structural lesion, proceed to:
TestReason
Anti-Yo, Anti-Hu, Anti-Ri, Anti-Tr (DNER), Anti-CASPR2, Anti-NMDAParaneoplastic cerebellar degeneration (subacute onset, male, 55 yrs)
Anti-GAD65 antibodiesCerebellar ataxia + DBN — strong association
ANA, ANCA, Anti-dsDNAAutoimmune cerebellar syndrome
Thyroid function (TSH, FT4)Hypothyroid cerebellar ataxia
Vitamin B12, Folate, ThiamineNutritional deficiency cerebellar syndrome
Genetic panel: SCA27B (FGF14 GAA repeat expansion)Late-onset cerebellar ataxia + DBN — now recognised as treatable
Serum copper and caeruloplasminWilson's / copper deficiency myelopathy

8. Ophthalmology Referral

  • Assess for oscillopsia severity and visual acuity impact
  • Prism lenses (base-out prisms) can reduce oscillopsia if nystagmus dampens on convergence — assess this clinically

PRIORITY 4 — PHARMACOTHERAPY (After Diagnosis Confirmed)

First-Line — 4-Aminopyridine (4-AP)

  • 4-AP 5–10 mg three times daily (TID) — currently the most evidence-based drug for downbeat nystagmus
  • Mechanism: voltage-gated potassium channel blocker → enhances cerebellar Purkinje cell excitability → restores inhibitory tone on vestibular pathways → reduces upward ocular drift
  • Evidence: Significantly reduces slow-phase velocity of DBN and improves oscillopsia-related disability
  • Sustained-release formulation (Fampridine/Dalfampridine 10 mg BD) may be more effective
  • Caution: Do NOT use if epilepsy history; do ECG first (prolongs QT risk at high doses); titrate slowly
  • More effective in cerebellar degeneration than structural focal lesions

Second-Line / Adjunctive

DrugDoseNote
Acetazolamide250 mg BD → titrate to 500–1000 mg/dayFirst-line if Episodic Ataxia Type 2 (EA2) confirmed; monitor electrolytes and renal function
Clonazepam0.5 mg BDIf 4-AP not tolerated; sedation limits long-term use
Clonazepam0.5 mg nocteUseful if positional DBN worsens at night
Gabapentin300 mg TIDIf torsional component is prominent

If Structural Cause Found

  • Chiari: Neurosurgical decompression (posterior fossa decompression) — may resolve DBN fully
  • Tumour: Onco-neurosurgery/oncology
  • Demyelination: Neurologist-directed disease-modifying therapy

PRIORITY 5 — VESTIBULAR REHABILITATION THERAPY (VRT)

Commence only after MRI is cleared / structural cause ruled out or treated

Rationale

Per Cummings Otolaryngology: "Studies have supported the use of vestibular rehabilitation in persons with both peripheral and central vestibular pathology." However, central VRT differs from peripheral VRT — it requires customized multisensory programs.

Recommended VRT Program

  1. Gaze Stabilization Exercises (x1 VOR cancellation) — compensate for impaired smooth pursuit and gaze-evoked nystagmus
  2. Vertical Saccade Training — to rehabilitate the severely compromised vertical saccade system
  3. Static and Dynamic Balance Training on progressively challenging surfaces
  4. Habituation exercises for positional vertigo — only after BPPV is definitively excluded
  5. Fall Prevention Protocol — given balance instability seen on Fukuda + gaze tests
  6. Sensory Organisation Training (SOT) — multi-sensory balance retraining
Do NOT perform Epley or Semont maneuvers — the positional nystagmus is central in pattern and repositioning maneuvers for BPPV are contraindicated and ineffective here.

PRIORITY 6 — PATIENT COUNSELLING & SAFETY

AdviceReason
Avoid driving until diagnosis is establishedRisk of sudden vertigo or drop attack
Avoid heights and laddersFall risk
Rise slowly from toilet/urinationMicturition syncope — sit for 1 minute post-voiding
Avoid alcohol and benzodiazepines (except prescribed)Worsen cerebellar signs
Sleep with head of bed elevated 20–30°Reduces downbeat nystagmus intensity in many patients
Avoid neck hyperextensionTriggers strongest nystagmus (Yacovino head extension positive)
Inform patient: this is NOT BPPV — repositioning at home is NOT safe or helpfulPrevent self-harm from attempting home Epley

FOLLOW-UP TIMELINE SUMMARY

TimelineAction
Day 0–3MRI Brain + Posterior Fossa with gadolinium; Neurology referral letter
Week 1–2Neurology review with MRI report; Cardiology Holter + Tilt Table
Week 2–4ECoG (left ear); vHIT; VEMP (cVEMP + oVEMP)
Week 4–6Blood investigations (paraneoplastic / autoimmune / genetic screen if MRI negative)
After MRI/diagnosisInitiate pharmacotherapy (4-AP) under Neurologist; Ophthalmology for oscillopsia
When structurally clearedCommence customised central VRT program
3 monthsRepeat VNG to assess for progression or improvement
6 monthsAudiological review (left SNHL monitoring); Repeat MRI if lesion found

Key message to the referring ENT consultant: The VNG data unambiguously shows a central vestibular disorder. This patient must be managed as a neurology/neuro-otology case, not a peripheral vestibular case. Starting vestibular rehabilitation without first clearing the posterior fossa with MRI would be a clinical error. The Valsalva-triggered nature of episodes (post-micturition) makes Chiari malformation a particularly important and urgent diagnosis to confirm or exclude.
References: Bradley and Daroff's Neurology in Clinical Practice (9780323642613); Cummings Otolaryngology (9780323612173); Lemos & Strupp, J Neurol 2022 [PMID 34669008]; Marcelli et al., Front Neurol 2024; Yacovino & Cherchi, J Neurol 2025 [PMID 39849040]

Create a comparison chart: peripheral BPPV vs. central positional downbeat nystagmus and last point on follow up pls provide

Finding Sources
Finding Sources
Searching the Web

peripheral BPPV vs central positional nystagmus comparison features latency fatigability fixation suppression 2024

Reading File
Reading File
Here is the comprehensive comparison chart followed by the final follow-up point:

COMPARISON CHART: Peripheral BPPV vs. Central Positional Downbeat Nystagmus


FeaturePeripheral BPPV (Posterior Canal)Central Positional DBN (Mr. Sanjay Garg)
Pathology siteInner ear — displaced otoconia in posterior semicircular canalCerebellar nodulus / uvula / vestibulocerebellum; brainstem
Symptom onsetSudden; triggered by specific head positionEpisodic; triggered by head extension, Valsalva (e.g., micturition)
Vertigo durationBrief — typically < 30 secondsVariable — can be prolonged or persistent
Nystagmus directionUpbeating + torsional (geotropic — toward the dependent ear)Downbeating — vertical, toward feet / chin; may be bilateral
Nystagmus planeMixed vertical-torsional (upward + rotatory)Pure vertical downbeat — central sign
LateralityUnilateral; ear-specific (affected side down)Bilateral and symmetric — same SPV both eyes both sides
Latency to onsetPresent — 2 to 20 seconds after positioningAbsent or very short — immediate or near-immediate onset
FatigabilityYes — weakens and disappears with repeated testingNo — non-fatiguing, reproduces consistently each time
Duration of nystagmusSelf-limiting < 60 secondsPersistent or very prolonged (> 1 minute)
Crescendo-decrescendo patternYes — classic "waxing-waning" patternAbsent — sustained, relatively constant intensity
Fixation suppressionYes — nystagmus reduces/disappears in light (fixation suppresses)No — nystagmus persists with fixation; worsens without fixation
Dix-Hallpike resultPositive on the affected side only; upbeat-torsionalPositive bilaterally with vertical (downbeat) nystagmus bilaterally — not side-specific
McClure-Pagnini (roll test)Positive in horizontal canal BPPV — geotropic/apogeotropicNegative in this case (horizontal canals uninvolved)
Yacovino testNegative / Not designed to be positive in BPPVStrongly positive — SPV up to 20 °/s; bilateral downbeat nystagmus in neck extension
Response to repositioning (Epley/Semont)Effective — resolves nystagmus and vertigoNo response — repositioning maneuvers are ineffective and potentially unsafe
Smooth pursuitNormal — unaffected in pure peripheral BPPVSeverely impaired bilaterally (gains 0.09–0.39) — cerebellar sign
SaccadesNormalVertical saccades profoundly abnormal (velocity ↓↓, precision ↓↓, latency ↑↑)
Post-headshake nystagmusHorizontal — beats away from affected earVertical — post-headshake vertical nystagmus = central sign
Gaze-evoked nystagmusAbsentPresent — multidirectional, worsens without fixation
Spontaneous nystagmus (dark)May be transiently present if acute labyrinthitis co-existsAbsent in this case (not spontaneous; positional)
Head Impulse Test (HIT/vHIT)Normal — VOR intact in BPPV (canals not hypofunction)Normal HIT expected — VOR may be intact; abnormal only if labyrinthine component co-exists
Caloric testNormal bilaterally in BPPVNot done in this study — may be needed to rule out canal paresis
HearingNormal — BPPV does not cause hearing lossLeft moderate SNHL (possibly co-existent Menière's or cochlear involvement)
Associated neurological signsNonePossible drop attacks; autonomic dysfunction (Valsalva-triggered episodes)
MRINormal — no posterior fossa lesionUrgent MRI required — may show Chiari, tumour, MS plaques, infarct
Otolith / VEMPUsually normaloVEMP asymmetry expected — otolith-ocular pathways involved
Natural historySelf-limiting; resolves in weeks; recurrences commonDependent on underlying cause — may be progressive if structural/degenerative
TreatmentCanalith Repositioning (Epley maneuver) — first-line4-Aminopyridine first-line; treat underlying cause (surgery if Chiari; DMT if MS)
Vestibular rehab (VRT)Habituation exercises post-maneuverCustomised central VRT — gaze stabilisation, balance, saccade training — after MRI clearance
PrognosisExcellent — > 90% resolve with 1–3 repositioning sessionsDepends entirely on aetiology; Chiari → surgical decompression can be curative

Sources: Harrison's Principles of Internal Medicine 22E (9781265977061); K.J. Lee's Essential Otolaryngology (9781260122237); Bradley & Daroff's Neurology in Clinical Practice (9780323642613); Lemos & Strupp, J Neurol 2022 [PMID 34669008]; Frontiers in Neurology, Acute positional vertigo in the ED 2023

FINAL FOLLOW-UP POINT (#7 — Long-Term Monitoring & Repeat Testing)

7. Long-Term Vestibular Monitoring and Repeat VNG

At 3 Months:
  • Repeat full VNG battery — specifically to assess whether:
    • Positional downbeat nystagmus SPV has increased (suggesting progressive lesion)
    • Smooth pursuit gains have improved (suggesting compensation or treatment response)
    • Vertical saccade metrics are worsening (suggests cerebellar degeneration)
  • If pharmacotherapy with 4-AP was initiated, compare pre/post SPV to assess drug efficacy objectively
At 6 Months:
  • Repeat MRI Brain if initial MRI was negative but symptoms persist or worsen — some lesions (radiographically occult infarction, early demyelination, paraneoplastic) may only become visible on follow-up imaging
  • Repeat audiological evaluation: pure tone audiometry + ECoG for left ear — monitor SNHL progression (rule out evolving endolymphatic hydrops)
  • Reassess for any new neurological symptoms: ataxia, diplopia, dysarthria, limb incoordination, headache — these would escalate the urgency of neurology review
Annually:
  • If genetic/metabolic cause confirmed (e.g., SCA27B, EA2), annual neurological follow-up with repeat neurophysiology is standard
  • Functional balance assessment — Computerised Dynamic Posturography (CDP) or standard Romberg/Tandem Gait — to monitor fall risk trajectory and guide rehabilitation intensity
  • Audiological review for left SNHL — pure tone audiometry annually
Key monitoring principle: In central positional DBN, the VNG is not a one-time test — it is a monitoring tool. Worsening SPV on serial VNG is a quantitative biomarker of disease progression and must directly inform the neurology management plan.

Search for latest research on cerebellar nodulus lesions and outcomes. And one last thing why do you always consider every case as AICA/PICA or VBI always you recommend posterior fossa MRI ?

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.
This is a shared conversation. Sign in to Orris to start your own chat.